Skip to main content
. 2021 Jan 22;15(1):e0009050. doi: 10.1371/journal.pntd.0009050

Table 2. Gastrointestinal clinical manifestations in HIV-associated disseminated histoplasmosis: nature and prevalence.

Variable n/N all patients with gastrointestinal signs and symptoms (%) n/N patients without any other concomitant opportunistic infection (%) n/N patients with a positive diagnosis on a gastrointestinal sample (%)
Abdominal pain 124/245 (50.6) 76/150 (50.7) 48/65 (73.8)
Diarrhea 123/245 (50.2) 76/150 (50.7) 46/65 (70.8)
mucoid-bloody /watery diarrhea 21/122 (17.2) 11/65 (14.5) 8/37 (17.8)
Liver enlargement 98/245 (40.0) 62/150 (41.3) 16/65 (24.6)
Splenomegaly 56/245 (22.8) 34/150 (22.7) 7/65 (10.8)
Anal lesions 9/245 (3.6) 7/150 (4.7) 2/65 (3.1)
Digestive complications 24/245 (9.8) 16/150 (10.7) 10/65 (15.4)
Ascites 9/245 (3.7) 7/150 (4.7) 3/65 (4.6)
Hemorrhage 7/24 (2.9) 5/150 (3.2) 3/65 (4.6)
Dysphagia 3/245 (1.2) 2/150 (1.3) 0/65 (0)
Subocclusion 2/245 (0.8) 2/150 (1.3) 2/65 (3.1)
Perforation 1/245 (0.4) 0/150 (0) 1/65 (1.5)
Vomiting+++ 1/245 (0.4) 0/150 (0) 0/65 (0)
Appendixectomy+right colonectomy 1/245 (0.4) 0/150 (0) 1/65 (1.5)
Peritonitis 1/245 (0.4) 0/150 (0) 1/65 (1.5)
Abdominal mass 1/245 (0.4) 1/150 (0.7) 1/65 (1.5)